Text Messaging Reminders for Influenza Vaccine in Primary Care (TXT4FLUJAB)
A Feasibility Study for a Cluster Randomised Trial of Text Messaging Reminders for Influenza Vaccine in Patients Under 65 in Clinical Risk Groups in English Primary Care.
Influenza morbidity and mortality cause a substantial financial burden to the NHS and to the UK as a whole. Influenza vaccine is safe and effective but is required annually because the circulating strain of virus changes each year. In the UK in 2012, the Chief Medical Officer (CMO) recommended that at least 75% of elderly people (aged 65+) and 75% people under 65 with certain chronic conditions (e.g. chronic heart disease, diabetes, asthma, etc) should be vaccinated. While primary care practices are achieving these targets for elderly patients, those set for younger patients with chronic conditions are not being met, with a third of patients being missed in the 2011/12 flu season and with no substantial improvements in uptake in the past decade. Therefore strategies to increase flu vaccine uptake in these patients are required.
Previous trials have shown that patient reminders can increase vaccine uptake and in particular, text messaging has shown to work in some populations in the United States as a cheap, simple and effective reminder. However, whether the same is true in UK general practice is unclear. The use of text messaging in the NHS for appointment reminders is also increasing as it is cheap, quick and effective. Text messaging is already used in roughly 30% of practices to remind patients about their flu vaccine but there has been no trial addressing its effectiveness. Therefore, we propose a trial of a text messaging flu vaccine reminder in patients aged under 65 who have a chronic condition. We hypothesise that practices that send a text message will have increased flu vaccine uptake.
調査の概要
研究の種類
入学 (実際)
段階
- 適用できない
連絡先と場所
研究場所
-
-
Select county
-
London、Select county、イギリス、WC1E 7HT
- London School of Hygiene and Tropical Medicine
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- practices must use text messaging software to communicate with patients;
- practices must not have used a text message to remind patients aged under 65 about influenza vaccine in the 2012/13 influenza season.
- practices will send the text message to eligible patients who are aged between 18 and 65, with one of the following risk conditions: chronic respiratory disease, chronic liver disease, chronic kidney disease, chronic heart disease, chronic neurological disease, immunosuppression
Exclusion Criteria:
- practices will not send the text message to pregnant women.
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:なし(オープンラベル)
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
他の:Standard care
Practices in the standard care arm will proceed with their seasonal influenza campaign as planned.
|
Practices in the standard care arm will be asked to proceed with their seasonal influenza campaign as planned.
|
|
実験的:Text messaging intervention
Practices in the text messaging intervention arm will be asked to send a text message to patients under 65 at risk of influenza.
|
Practices in the text messaging intervention arm will be asked to send a text message to patients under 65 at risk of influenza.
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
時間枠 |
|---|---|
|
Proportion of patients at risk who received flu vaccine
時間枠:up to 9 months
|
up to 9 months
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Proportion of practices reporting 'yes' to difficulties
時間枠:up to 3 months
|
Proportion of practices reporting 'yes' that they had difficulties in sending the text message to patients
|
up to 3 months
|
|
Recruitment rate
時間枠:3 months after initial contact
|
This is a pilot feasibility study and recruitment of practices to the trial is an outcome.
|
3 months after initial contact
|
|
Practice delivery of text message
時間枠:One month after study start (October 1st 2013)
|
Did the practice send the text message to eligible patients and was the content of the message as described in the protocol.
|
One month after study start (October 1st 2013)
|
|
Were outcome data available
時間枠:up to 9 months
|
Were outcome data regarding text message and flu vaccine uptake available.
|
up to 9 months
|
協力者と研究者
研究記録日
主要日程の研究
研究開始
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (見積もり)
学習記録の更新
投稿された最後の更新 (見積もり)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
キーワード
追加の関連 MeSH 用語
その他の研究ID番号
- txt4flujab
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。